2019
DOI: 10.1101/838409
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Variation at the Klotho gene locus does not affect cognitive function in up to 335,074 British Caucasians in the UK Biobank

Abstract: 25The proportion of older adults in Western populations is increasing and there is, 26 therefore, a need to define factors affecting maintenance of physical and 27 cognitive health in old age. Variations in the Klotho (KL) gene, and specifically 28 the KL-VS haplotype, have been identified by several authors as potentially 29 influencing cognitive function and decline. We have attempted to verify the 30 reported associations between KL variants, including the KL-VS haplotype, and 31 cognitive function in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Finally, UKBB had a relatively lower AD incidence rate than many other cohorts reported. We reasoned that in UKBB, the population evaluated had a shorter follow-up time and that more AD incident cases would be observed when the study continued to evolve [72]. Nevertheless, our study using three different cohorts suggests a role for the clinical biomarker CRP used under infection or inflammation conditions in monitoring risk in those with specific genetic factors for AD development as well as a role in precision medicine-based drug development.…”
Section: Discussionmentioning
confidence: 97%
“…Finally, UKBB had a relatively lower AD incidence rate than many other cohorts reported. We reasoned that in UKBB, the population evaluated had a shorter follow-up time and that more AD incident cases would be observed when the study continued to evolve [72]. Nevertheless, our study using three different cohorts suggests a role for the clinical biomarker CRP used under infection or inflammation conditions in monitoring risk in those with specific genetic factors for AD development as well as a role in precision medicine-based drug development.…”
Section: Discussionmentioning
confidence: 97%